Blockade of death ligand TRAIL inhibits renal ischemia reperfusion injury

Acta Histochemica et Cytochemica

Volumn 46, Issue 6, 2013, Pages 161-170

  Adachi, Takaomi ^a   Sugiyama, Noriyuki ^a,b   Gondai, Tatsuro ^a   Yagita, Hideo ^c   Yokoyama, Takahiko ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Fibrosis; Ischemia reperfusion injury; TNF superfamily; TRAIL

Indexed keywords

EID: 84891431183     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.13022     Document Type: Article

References (46)

1. Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., DeForge, L., Koumenis, I. L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z. and Schwall, R. H. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104; 155-162.
2. Bonegio, R. and Lieberthal, W. (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr. Opin. Nephrol. Hypertens. 11; 301-308.
3. Bonventre, J. V. and Yang, L. (2011) Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121; 4210-4221.
4. Cantarella, G., Di Benedetto, G., Scollo, M., Paterniti, I., Cuzzocrea, S., Bosco, P., Nocentini, G., Riccardi, C. and Bernardini, R. (2012) Neutralization of tumor necrosis factorrelated apoptosis-inducing ligand reduces spinal cord injury damage in mice. Neuropsychopharmacology 35; 1302-1314.
5. Chawla, L. S., Amdur, R. L., Amodeo, S., Kimmel, P. L. and Palant, C. E. (2011) The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int. 79; 1361-1369.
6. Coca, S. G., Yusuf, B., Shlipak, M. G., Garg, A. X. and Parikh, C. R. (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 53; 961-973.
7. Collison, A., Foster, P. S. and Mattes, J. (2009) Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses. Clin. Exp. Pharmacol. Physiol. 36; 1049-1053.
8. Cretney, E., Takeda, K., Yagita, H., Glaccum, M., Peschon, J. J. and Smyth, M. J. (2002) Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing liganddeficient mice. J. Immunol. 168; 1356-1361.
9. Cretney, E., McQualter, J. L., Kayagaki, N., Yagita, H., Bernard, C. C., Grewal, I. S., Ashkenazi, A. and Smyth, M. J. (2005) TNFrelated apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol. Cell Biol. 83; 511-519.
10. Daemen, M. A., van de Ven, M. W., Heineman, E. and Buurman, W. A. (1999) Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation 67; 792-800.
11. Di Pietro, R. and Zauli, G. (2004) Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L. J. Cell. Physiol. 201; 331-340.
12. Diehl, G. E., Yue, H. H., Hsieh, K., Kuang, A. A., Ho, M., Morici, L. A., Lenz, L. L., Cado, D., Riley, L. W. and Winoto, A. (2004) TRAIL-R as a negative regulator of innate immune cell responses. Immunity 21; 877-889.
13. Ehrhardt, H., Wachter, F., Grunert, M. and Jeremias, I. (2013) Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis. Cell Death Dis. 4; e661.
14. Emery, J. G., McDonnell, P., Burke, M. B., Deen, K. C., Lyn, S., Silverman, C., Dul, E., Appelbaum, E. R., Eichman, C., DiPrinzio, R., Dodds, R. A., James, I. E., Rosenberg, M., Lee, J. C. and Young, P. R. (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273; 14363-14367.
15. Fernandez Fernandez, B., Elewa, U., Sanchez-Nino, M. D., Rojas-Rivera, J. E., Martin-Cleary, C., Egido, J. and Ortiz, A. (2012) 2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials. Minerva Med. 103; 219-234.
16. Forbes, J. M., Hewitson, T. D., Becker, G. J. and Jones, C. L. (2000) Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney Int. 57; 2375-2385.
17. Hamar, P., Song, E., Kokeny, G., Chen, A., Ouyang, N. and Lieberman, J. (2004) Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U S A 101; 14883-14888.
18. Hilliard, B., Wilmen, A., Seidel, C., Liu, T. S., Goke, R. and Chen, Y. (2001) Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J. Immunol. 166; 1314-1319.
19. Hotta, K., Sho, M., Yamato, I., Shimada, K., Harada, H., Akahori, T., Nakamura, S., Konishi, N., Yagita, H., Nonomura, K. and Nakajima, Y. (2011) Direct targeting of fibroblast growth factorinducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int. 79; 179-188.
20. Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P. and Zhou, T. (2001) Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat. Med. 7; 954-960.
21. Jo, S. K., Sung, S. A., Cho, W. Y., Go, K. J. and Kim, H. K. (2006) Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol. Dial. Transplant. 21; 1231-1239.
22. Kayagaki, N., Yamaguchi, N., Nakayama, M., Takeda, K., Akiba, H., Tsutsui, H., Okamura, H., Nakanishi, K., Okumura, K. and Yagita, H. (1999) Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 163; 1906-1913.
23. Ko, G. J., Jang, H. R., Huang, Y., Womer, K. L., Liu, M., Higbee, E., Xiao, Z., Yagita, H., Racusen, L., Hamad, A. R. and Rabb, H. (2011) Blocking Fas ligand on leukocytes attenuates kidney ischemia-reperfusion injury. J. Am. Soc. Nephrol. 22; 732-742.
24. Kumar, D., Robertson, S. and Burns, K. D. (2004) Evidence of apoptosis in human diabetic kidney. Mol. Cell. Biochem. 259; 67-70.
25. Linkermann, A., Brasen, J. H., Himmerkus, N., Liu, S., Huber, T. B., Kunzendorf, U. and Krautwald, S. (2012) Rip1 (receptorinteracting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int. 81; 751-761.
26. Lorz, C., Benito-Martin, A., Boucherot, A., Ucero, A. C., Rastaldi, M. P., Henger, A., Armelloni, S., Santamaria, B., Berthier, C. C., Kretzler, M., Egido, J. and Ortiz, A. (2008) The death ligand TRAIL in diabetic nephropathy. J. Am. Soc. Nephrol. 19; 904-914.
27. Okusa, M. D., Linden, J., Huang, L., Rieger, J. M., Macdonald, T. L. and Huynh, L. P. (2000) A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am. J. Physiol. Renal Physiol. 279; F809-818.
28. Perico, N., Cattaneo, D., Sayegh, M. H. and Remuzzi, G. (2004) Delayed graft function in kidney transplantation. Lancet 364; 1814-1827.
29. Sanchez-Niño, M. D., Benito-Martin, A., Gonçalves, S., Sanz, A. B., Ucero, A. C., Izquierdo, M. C., Ramos, A. M., Berzal, S., Selgas, R., Ruiz-Ortega, M., Egido, J. and Ortiz, A. (2010) TNF superfamily: a growing saga of kidney injury modulators. Mediators Inflamm. 2010; 182958.
30. Schneider, P., Olson, D., Tardivel, A., Browning, B., Lugovskoy, A., Gong, D., Dobles, M., Hertig, S., Hofmann, K., Van Vlijmen, H., Hsu, Y. M., Burkly, L. C., Tschopp, J. and Zheng, T. S. (2003) Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Biol. Chem. 278; 5444-5454.
31. Secchiero, P., Gonelli, A., Mirandola, P., Melloni, E., Zamai, L., Celeghini, C., Milani, D. and Zauli, G. (2002) Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. Blood 100; 2421-2429.
32. Secchiero, P., Gonelli, A., Carnevale, E., Milani, D., Pandolfi, A., Zella, D. and Zauli, G. (2003) TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107; 2250-2256.
33. Secchiero, P., Melloni, E., Heikinheimo, M., Mannisto, S., Di Pietro, R., Iacone, A. and Zauli, G. (2004) TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood 103; 517-522.
34. Secchiero, P., Zerbinati, C., Rimondi, E., Corallini, F., Milani, D., Grill, V., Forti, G., Capitani, S. and Zauli, G. (2004) TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Cell. Mol. Life Sci. 61; 1965-1974.
35. Shiba, D., Yamaoka, Y., Hagiwara, H., Takamatsu, T., Hamada, H. and Yokoyama, T. (2009) Localization of Inv in a distinctive intraciliary compartment requires the C-terminal nineinhomolog-containing region. J. Cell Sci. 122; 44-54.
36. Song, C. J., Liu, X. S., Zhu, Y., Chen, L. H., Jia, W., Li, Y. N., Cao, Y. X., Xie, X., Zhuang, R., Zhu, C. S. and Jin, B. Q. (2004) Expression of TRAIL, DR4, and DR5 in kidney and serum from patients receiving renal transplantation. Transplant. Proc. 36; 1340-1343.
37. Sugiyama, N. and Yokoyama, T. (2006) Sustained cell proliferation of renal epithelial cells in mice with inv mutation. Genes Cells. 11; 1213-1224.
38. Sugiyama, N., Kohno, M. and Yokoyama, T. (2012) Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model. Nephrol. Dial. Transplant. 27; 1351-1358.
39. Takeda, K., Stagg, J., Yagita, H., Okumura, K. and Smyth, M. J. (2007) Targeting death-inducing receptors in cancer therapy. Oncogene 26; 3745-3757.
40. Ursini-Siegel, J., Zhang, W., Altmeyer, A., Hatada, E. N., Do, R. K., Yagita, H. and Chen-Kiang, S. (2002) TRAIL/Apo-2 ligand induces primary plasma cell apoptosis. J. Immunol. 169; 5505-5513.
41. Wald, R., Quinn, R. R., Luo, J., Li, P., Scales, D. C., Mamdani, M. M. and Ray, J. G.; University of Toronto Acute Kidney Injury Research Group. (2009) Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302; 1179-1185.
42. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3; 673-682.
43. Wu, G. S., Burns, T. F., Zhan, Y., Alnemri, E. S. and El-Deiry, W. S. (1999) Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res. 59; 2770-2775.
44. Xue, J. L., Daniels, F., Star, R. A., Kimmel, P. L., Eggers, P. W., Molitoris, B. A., Himmelfarb, J. and Collins, A. J. (2006) Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J. Am. Soc. Nephrol. 17; 1135-1142.
45. Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V. and Bonventre, J. V. (2010) Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med. 16; 535-543.
46. Zheng, S. J., Wang, P., Tsabary, G. and Chen, Y. H. (2004) Critical roles of TRAIL in hepatic cell death and hepatic inflam-mation. J. Clin. Invest. 113; 58-64.